Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval

The Journal of Clinical Endocrinology and Metabolism
J A M J L JanssenF H Schröder

Abstract

Recent studies have reported that serum IGF-I levels in the highest quartile of the normal range and IGF binding protein-3 (IGFBP-3) in the lowest quartile of the normal range are associated with an increased risk of future prostate cancer and/or presence of prostate cancer. It has also been suggested that the measurement of circulating total IGF-I concentrations might be a useful tool for the early detection of prostate cancer in men with moderately increased prostate-specific antigen (PSA) levels. To determine whether circulating free IGF-I, total IGF-I, and IGFBP-3 levels can predict future prostate cancer risk, we prospectively studied prostate cancer characteristics in a cohort of men during two rounds (mean interval, 4 yr) of a population-based screening study for prostate cancer. Two hundred one prostate cancer cases were detected at the second-round screening (aged 55-70 yr), and all these subjects were enrolled in the case group for the present study. Prostate cancer had been confirmed by biopsy in all cases. These 201 subjects were matched with the 201 nonprostate cancer cases by age, serum PSA range at the first-round screening (PSA < 2 ng/ml, n = 67; PSA = 2-3 ng/ml, n = 67; and PSA = 3-4 ng/ml, n = 67), and residen...Continue Reading

References

Mar 1, 1992·Human Pathology·D F Gleason
Jan 1, 1992·The Prostate. Supplement·F H SchröderM Pavone-Macaluso
Jan 1, 1994·Breast Cancer Research and Treatment·R WinstonD T Kiang
Jul 11, 1994·FEBS Letters·J FrystykH Orskov
Jan 1, 1995·Progress in Growth Factor Research·B TönshoffO Mehls
Jan 1, 1997·British Journal of Cancer·C S MantzorosH O Adami
Jun 24, 1998·Journal of the National Cancer Institute·A WolkD Trichopoulos
Jun 15, 1999·BJU International·C W CuttingR S Kirby
Jul 15, 1999·International Journal of Cancer. Journal International Du Cancer·P M BeemsterboerF H Schröder
Nov 24, 1999·Journal of the National Cancer Institute·L B SignorelloH O Adami
Jul 25, 2000·Endocrine·P F Collett-Solberg, P Cohen
Nov 30, 2000·The Journal of Clinical Endocrinology and Metabolism·S M HarmanUNKNOWN Baltimore Longitudinal Study on Aging
Feb 7, 2001·The Journal of Clinical Endocrinology and Metabolism·J KhosraviA Scorilas
Sep 12, 2001·World Journal of Urology·B DjavanM Marberger
Oct 11, 2001·British Journal of Cancer·R ShiH Yu
Jul 18, 2002·Journal of the National Cancer Institute·June M ChanEdward Giovannucci
Sep 4, 2003·Journal of Endocrinological Investigation·J A M J L JanssenS W J Lamberts
Oct 2, 2003·Journal of the National Cancer Institute·Ingrid W van der Cruijsen-KoeterFritz H Schröder
Nov 20, 2003·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Andrew G RenehanStephen M Shalet

❮ Previous
Next ❯

Citations

Nov 11, 2008·Journal of Endocrinological Investigation·A GiustinaUNKNOWN European Neuroendocrine Association
Mar 28, 2008·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Donald T WigleMarie-Elise Parent
Jan 15, 2009·International Journal of Cancer. Journal International Du Cancer·Mari-Anne RowlandsRichard M Martin
May 4, 2011·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Mohammad Reza SafarinejadShiva Safarinejad
Apr 1, 2005·International Journal of Cancer. Journal International Du Cancer·François MeyerSerge Hercberg
May 4, 2006·The Journal of Clinical Endocrinology and Metabolism·Imogen RogersUNKNOWN Avon Longitudinal Study of Parents Children Study Team
Feb 21, 2009·International Journal of Cancer. Journal International Du Cancer·Katie M ApplebaumKarl T Kelsey
Apr 4, 2014·Biological & Pharmaceutical Bulletin·Chuanying XuYan Yu
May 11, 2005·The American Journal of Clinical Nutrition·Susanna C LarssonAlicja Wolk
Jun 6, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Naomi E AllenRudolf Kaaks
Nov 5, 2019·Journal of the Neurological Sciences·Johanna Andrea Gutiérrez-Vargas, Gloria Patricia Cardona-Gómez
Nov 5, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Chris H BangmaUlf-Håkan Stenman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.